Neuropathic pain, caused by a lesion or disease affecting the somatosensory system, affects
between 3 and 17% of the general population. The treatment of neuropathic pain is …

Trigeminal neuralgia (TN), the most common craniofacial neuralgia, results in intense,
debilitating facial pain and can profoundly affect quality of life. In this article, the authors …

Pharmaceuticals are an important class of micropollutants within the freshwater
environment. There is sufficient evidence of their impacts on exposed biota to warrant further …

Trigeminal neuralgia (TN) is a complex orofacial pain syndrome characterized by the
paroxysmal onset of pain attacks in the trigeminal distribution. The underlying mechanism …

Neuropathic pain (NP) is a chronic pain disorder arising from somatosensory nervous
system impairment. Extensive evidence supports the notion that the gut microbiota (GM) is …

Background The primary aim of this observational study was to determine the incidence of
trigeminal neuralgia (TN) in a county in central Sweden. The secondary aim was to …

Nearly 5 decades ago, the effect of trigeminal nerve stimulation (TNS) on cerebral blood flow
was observed for the first time. This implication directly led to further investigations and …

Trigeminal neuralgia (TN), the most common form of severe facial pain, may be confused
with an ill-defined persistent idiopathic facial pain (PIFP). Facial pain is reviewed and a …

Tailor-made AAs are indispensable components of modern medicinal chemistry and are
becoming increasingly prominent in new drugs. In fact, about 30% of small-molecule …

Background Scant evidence is available on the use of intravenous pain treatment in acute
exacerbations of trigeminal neuralgia. The aim of this descriptive study was to evaluate the …